Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.01

-0.2%

10:36 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	8/9/2006 5:22:47 PM
	Read Replies (1) of 52153

Peter, Perhaps I'll change my Lipitor Sales estimate to an increase of 5-10%. :^) Ian Pfizer's Lipitor Shown to Reduce the Chance of Additional Strokes in Stroke Patients prnews - Stroke Patients With Mildly Elevated Cholesterol Levels Who Took Lipitor Reduced Their Risk of Additional Strokes by 16 Percent - Lipitor Patients Also Had a 35 Percent Reduction in Risk of Major Coronary Events Such as Heart Attack - Investigator: 'This is Important Information for Physicians Because Patients Who Have Had a Stroke Are At Much Greater Risk for Suffering Another One, Yet Treatment Options to Reduce Their Risk Are Limited.' NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Patients taking Lipitor(R) (atorvastatin calcium) Tablets (80 mg) who had a prior stroke reduced their chances of having an additional stroke and major coronary event such as heart attack, according to results from the first major study designed to examine the benefits of lipid lowering in stroke patients. [SNIP]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next